Evidence date · 2022-04-29 · Research note 3 of 3
1 2 3
See current Track status →
Since the previous research note · Earlier expectation not tested
Track continuity
Since the previous research note: When acting out dreams and REM sleep recordings do not align
Previous expectation: Understanding why dream enactment and sleep recordings disagree might eventually help clinicians tailor neurological follow-up.
What this study adds: This registry describes a family cohort with isolated sleep features and more early markers among relatives of affected patients than among relatives of controls, motivating prospective follow-up. It brings a family-population comparison into the timeline without testing whether the earlier mismatch distinction improves clinical decisions.
What changed in this study
The ClinicalTrials.gov registry entry for Progression Follow up of the First-degree Relatives of Patients With REM Sleep Behavior Disorder, published April 29, 2022, describes a shift in focus. Instead of studying only people who already have the disorder, researchers are following their first-degree relatives and comparing them with relatives of control participants.
The aim is to learn whether isolated sleep or neurological features appear differently across the two family groups and whether observations over time can clarify how the disorder develops. A family pattern can motivate that investigation without determining any individual’s future.
A disorder seen in behavior and on a sleep recording
REM sleep behavior disorder involves recurrent dream-enactment behaviors together with a sleep-recording finding called REM sleep without atonia. During normal REM sleep, muscle activity is greatly reduced. With REM sleep without atonia, that usual reduction is absent or incomplete.
A relative might show one part of this picture without having the full disorder established. The registry describes dream-related movements, other REM-sleep behavioral events and REM sleep without atonia as isolated features found among relatives. These are different kinds of observations: one concerns what happens during sleep, while the other concerns what a recording detects.
The family comparison behind the study
The baseline case-control family cohort included 208 first-degree relatives of people with idiopathic REM sleep behavior disorder and 204 first-degree relatives of controls. First-degree relatives are close family members such as parents, siblings or children.
The investigators reported familial aggregation of REM sleep behavior disorder and related neurodegenerative features. They also described more prodromal markers among relatives of affected patients than among relatives of controls. Examples included excessive daytime sleepiness, constipation and subthreshold parkinsonism, meaning subtle movement-related signs that had not become a diagnosed disorder.
These group-level findings make the cohort useful for prospective research. They do not establish a genetic cause, show a fixed sequence from one feature to the next or provide a numerical forecast for a particular relative.
Early repeat assessments add a time dimension
The registry summary also describes preliminary follow-up observations. About 85 unaffected first-degree relatives in each group had repeat assessments after a mean follow-up of about four years. The investigators reported persistent familial aggregation of REM sleep behavior disorder symptoms and continued loading of prodromal markers such as possible REM sleep behavior disorder and subthreshold parkinsonism.
The preliminary data also indicated a seemingly faster progression toward prodromal REM sleep behavior disorder among relatives of patients with idiopathic REM sleep behavior disorder than among relatives of controls. These observations move the story beyond a single baseline comparison, but they remain preliminary group findings. They are not the completed results of the longer follow-up proposed in the registry.
The proposed longer follow-up
The registry describes a prospective study with a mean follow-up interval of about seven years. Researchers proposed reassessing autonomic symptoms, motor signs, neurocognitive function, sleepiness, video polysomnography and one-week actigraphy, along with the development of clinical neurodegenerative disease. Home polysomnography with body-movement monitoring was also proposed to help identify sleep-related features when access to hospital testing was restricted.
Following participants over time changes the question. Researchers can ask which isolated findings persist, which appear later and which are associated with progression toward a more complete sleep disorder. Family clustering supplies a reason to look closely; longitudinal observation is needed to learn whether a feature reliably comes before another one. The registry describes observation, not a treatment trial or a recommendation that relatives should be screened.
What this could change
A reliable earlier window in the development of REM sleep behavior disorder could eventually help researchers enroll affected families before the full disorder is expressed and study potential protective interventions at that stage. If a later intervention were shown to work, identifying that window could create a path toward delaying neurodegenerative disease or its progression.
Both steps are necessary. The family comparisons and preliminary repeat assessments provide a reason to keep following the question, while the proposed prospective work must establish which features genuinely precede progression. Demonstrating that an intervention protects health would require separate evidence.
Key Sources
- Primary source: Progression Follow up of the First-degree Relatives of Patients With REM Sleep Behavior Disorder
Government or Regulator · Clinical Trial · 2022-04-29